Brokerage house Firstcall Research is bullish on Sharon Bio Medicine and has recommended buy rating on the stock with a target price of Rs 326 in its August 31, 2013 research report.
Firstcall Research is bullish on Sharon Bio Medicine and has recommended buy rating on the stock with a target of Rs 458 in its August 27, 2012 research report.